BioCentury
ARTICLE | Company News

Eli Lilly neurology, musculoskeletal, cancer news

July 22, 2013 7:00 AM UTC

Eli Lilly said it is suspending base pay increases for most employees, including executives, in 2014 to curb the impact of the expiration of U.S. patents for neurology drug Cymbalta duloxetine and os...